Rexnord (RXN:NYS) Fundamental Valuation Report

Fundamental Valuation Report

Rexnord(RXN:NYS)

Industrials:Diversified Industrials

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$24.04 (USD) 15/01/2019

Weighted Valuation
$28.32 (USD)

Overall Rating
Undervalued by 17.8%

Valuation Models Analyst Consensus: $30.50 (USD)
(in order of importance) Comparables: $25.35 (USD)
Multiples: $27.74 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Undervalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (RXN:NYS USD)

Price 24.04
Range 23.66 – 24.18
52 week 21.70 – 31.86
Open 23.93
Vol / Avg. 414349/655197
Mkt cap 2.52B
P/E 44.29
Div/yield 0.00/0.00
EPS 0.50
Shares 104.66M
Beta 1.54

Company Description

Rexnord Corp is a U.S.-based company that primarily operates through two segments. Its process and motion control segment designs, manufactures, and distributes specified mechanical components that are used in complex systems, as well as providing related services. This segment’s customers come from food and beverage, aerospace, mining, energy and power generation, and other industries. The water management segment manufactures and markets products that can help enhance water quality and conservation. This segment’s target customers primarily include nonresidential buildings and water and wastewater treatment infrastructures. The company generates most of its revenue from American and European markets.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for RXN:NYS

Using a discounted cash flow model we generated an intrinsic value of $60.56 (USD) for RXN:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

RXN:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $60.56 1% 5% 1% 5%
WACC (or Ke) 10.00 $73.52 $50.84
Terminal Growth Rate 3.00 $51.96 $72.03
Tax Rate -0.35 $63.63 $57.49
Cash Flow 513,249,000 $56.27 $64.85
Capital Expenditures -46,380,000 $60.27 $60.85
Long Term Debt 1,822,700,000 $61.43 $59.69

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $25.35 (USD) for RXN:NYS. We also generated a valuation of $36.26 (USD) using other metrics and comparables.
The comparable companies were Altra Industrial Motion (AIMC:NAS), Actuant (ATU:NYS), Hillenbrand (HI:NYS), Mueller Water Products (MWA:NYS) and Raven Industries (RAVN:NAS).

Company RXN:NYS End Date Value
Earnings/Share ($0.40) (USD)
Book Value/Share $10.93 (USD)
Sales/Share $20.54 (USD)
Cash Flow/Share $2.27 (USD)
EBITDA/Share $2.07 (USD)
Price Based on Comps Adjustment Factor (%)
($8.22) (USD) 0.0
$35.58 (USD) 7.2
$32.86 (USD) -24.4
$15.15 (USD) -21.1
$26.32 (USD) 20.5
RXN:NYS Ratios Used Average Values AIMC:NAS ATU:NYS HI:NYS MWA:NYS RAVN:NAS
30.60 PE Ratio 20.55 13.90 0.00 31.61 13.79 22.91
2.10 PB Ratio 3.25 3.89 2.39 3.24 2.55 4.21
1.12 PS Ratio 1.60 0.79 1.07 1.37 1.59 3.18
10.10 PCF Ratio 12.24 7.63 13.08 9.75 10.92 19.84
13.81 EV to EBITDA 12.69 14.19 10.77 13.30 9.45 15.74

Multiples

Using a multiples approach we generated a valuation of  $27.74 (USD) for RXN:NYS

Company RXN:NYS End Date Value
Earnings/Share ($0.40) (USD)
Book Value/Share $10.93 (USD)
Sales/Share $20.54 (USD)
Cash Flow/Share $2.27 (USD)
EBITDA/Share $2.07 (USD)
Price Based on Comps Adjustment Factor
$0.00 (USD) 0
$33.36 (USD) 0
$25.88 (USD) 0
$25.83 (USD) 0
$25.91 (USD) 0
Ratios Ratio Average
PE Ratio 31.64
PB Ratio 3.05
PS Ratio 1.26
PCF Ratio 11.37
EV to EBITDA 12.50

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  RXN:NYS for the last 6 years was  3.06

We ran the Adjusted Book Value for  RXN:NYS and generated a book value of  $10.98 (USD)
By multiplying these we get an adjusted valuation of  $33.55 (USD)

Analyst Data

In the Stockcalc database there are 2 analysts that provide a valuation for RXN:NYS. The 2 analysts have a concensus valuation for RXN:NYS for 2020 of $30.50 (USD).

RXN:NYS Rexnord

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
1 1 0 4.0000 Outperform 2019-1-14

Current Price: 24.04 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 1.73 2.03 2.18
# EPS Analysts 2 2 1
Mean Revenue 2,059.50 2,149.10 2,255.50
# Revenue Analysts 2 2 1
Mean Target Price 30.50
Mean Cash Flow 2.02 2.35 2.40
Mean EBITDA 440.10 480.10 498.30
Mean Net Income 203.70 237.20 281.50
Mean Debt Outstanding 955.70 743.70 558.40
Mean Tax Rate 27.20 27.50
Mean Growth Rate 12.00
Mean Capital Expenditure 45.10 48.60 56.40

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


New Relic (NEWR:NYS) Fundamental Valuation Report

Fundamental Valuation Report

New Relic(NEWR:NYS)

Technology:Software-Infrastructure

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$89.11 (USD) 15/01/2019

Weighted Valuation
$105.11 (USD)

Overall Rating
Undervalued by 18.0%

Valuation Models Analyst Consensus: $107.25 (USD)
(in order of importance) Multiples: $101.91 (USD)
Valuation Methods This company is:
Cash Flow: Overvalued on a Cash Flow Valuation
Comparable Company: Overvalued on a Comparable Valuation
Asset: Overvalued on an Asset Valuation

Company Overview (NEWR:NYS USD)

Price 89.11
Range 86.81 – 89.62
52 week 57.75 – 113.44
Open 87.78
Vol / Avg. 487174/549222
Mkt cap 5.08B
P/E 0.00
Div/yield 0.00/0.00
EPS -0.83
Shares 56.96M
Beta 0.00

Company Description

New Relic Inc is a provider of software analytics solutions for organizations to collect, store, and analyze massive amounts of software data in real time. The firm’s flagship New Relic Software Analytics Cloud is made up of a suite of products, a Big Data database, and an open platform. Its solutions include diagnostics, reporting and alerting, transaction monitoring, and performance monitoring capabilities. The firm generates revenue from subscription-based arrangements for software offerings, typically for a year. A majority of the firm’s revenue is generated in the United States, and the rest from Europe, the Middle East, and Africa; the Asia-Pacific; and other regions.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for NEWR:NYS

Using a discounted cash flow model we generated an intrinsic value of $31.75 (USD) for NEWR:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

NEWR:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $31.75 1% 5% 1% 5%
WACC (or Ke) 7.91 $39.90 $26.32
Terminal Growth Rate 2.90 $26.80 $39.17
Tax Rate 0.02 $33.19 $30.35
Cash Flow 105,678,300 $30.14 $33.37
Capital Expenditures -21,604,200 $31.46 $32.05
Long Term Debt 0 $31.75 $31.75

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $116.80 (USD) for NEWR:NYS. We also generated a valuation of $66.59 (USD) using other metrics and comparables.
The comparable companies were Fair Isaac (FICO:NYS), Guidewire Software (GWRE:NYS), j2 Global (JCOM:NAS), Q2 Holdings (QTWO:NYS) and 2U (TWOU:NAS).

Company NEWR:NYS End Date Value
Earnings/Share ($0.51) (USD)
Book Value/Share $5.58 (USD)
Sales/Share $7.39 (USD)
Cash Flow/Share $1.38 (USD)
EBITDA/Share ($0.38) (USD)
Price Based on Comps Adjustment Factor (%)
$0.00 (USD) 0.0
$51.08 (USD) 0.0
$49.67 (USD) 0.0
$249.66 (USD) 0.0
($13.01) (USD) 0.0
NEWR:NYS Ratios Used Average Values FICO:NYS GWRE:NYS JCOM:NAS QTWO:NYS TWOU:NAS
0.00 PE Ratio 33.85 40.92 0.00 26.79 0.00 0.00
14.51 PB Ratio 9.15 20.53 4.37 3.27 13.43 4.16
10.96 PS Ratio 6.72 5.65 8.70 2.88 9.31 7.06
58.62 PCF Ratio 180.74 26.14 44.13 8.94 492.06 332.43
250.72 EV to EBITDA 34.60 24.40 69.32 10.06 0.00 0.00

Multiples

Using a multiples approach we generated a valuation of  $101.91 (USD) for NEWR:NYS

Company NEWR:NYS End Date Value
Earnings/Share ($0.51) (USD)
Book Value/Share $5.58 (USD)
Sales/Share $7.39 (USD)
Cash Flow/Share $1.38 (USD)
EBITDA/Share ($0.38) (USD)
Price Based on Comps Adjustment Factor
$0.00 (USD) 0
$60.50 (USD) 0
$72.63 (USD) 0
$172.60 (USD) 0
$0.00 (USD) 0
Ratios Ratio Average
PE Ratio 0.00
PB Ratio 10.84
PS Ratio 9.83
PCF Ratio 124.96
EV to EBITDA 0.00

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  NEWR:NYS for the last 4 years was  10.99

We ran the Adjusted Book Value for  NEWR:NYS and generated a book value of  $5.68 (USD)
By multiplying these we get an adjusted valuation of  $62.42 (USD)

Analyst Data

In the Stockcalc database there are 4 analysts that provide a valuation for NEWR:NYS. The 4 analysts have a concensus valuation for NEWR:NYS for 2020 of $107.25 (USD).

NEWR:NYS New Relic

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
4 2 0 4.3333 Outperform 2019-1-14

Current Price: 89.11 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 0.38 0.69 1.06
# EPS Analysts 5 5 2
Mean Revenue 510.00 606.30 741.10
# Revenue Analysts 5 5 2
Mean Target Price 107.25
Mean Cash Flow 1.24 1.63 2.17
Mean EBITDA 63.80 72.00 102.70
Mean Net Income 28.70 41.90 68.60
Mean Debt Outstanding -328.50 -381.70 -470.60
Mean Tax Rate 3.00 3.50 21.00
Mean Growth Rate 14.00
Mean Capital Expenditure 41.70 42.20 56.60

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Prestige Consumer (PBH:NYS) Fundamental Valuation Report

Fundamental Valuation Report

Prestige Consumer(PBH:NYS)

Healthcare:Medical Distribution

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$28.10 (USD) 15/01/2019

Weighted Valuation
$33.92 (USD)

Overall Rating
Undervalued by 20.7%

Valuation Models Analyst Consensus: $38.00 (USD)
(in order of importance) Comparables: $27.79 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Fairly valued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (PBH:NYS USD)

Price 28.10
Range 26.35 – 28.17
52 week 28.10 – 46.03
Open 26.36
Vol / Avg. 1.17M/585154
Mkt cap 1.45B
P/E 6.10
Div/yield 0.00/0.00
EPS 6.34
Shares 51.74M
Beta 1.20

Company Description

Prestige Consumer Healthcare Inc, formerly Prestige Brands distributes branded over-the-counter healthcare and household cleaning products to mass merchandisers, drug stores, convenience stores, and supermarkets. The firm’s major brands include Chloraseptic, Clear Eyes, Compound W, Dramamine, and Comet. Prestige Brands operates in three segments: North American over-the-counter, or OTC healthcare; international over-the-counter healthcare; and household cleaning. The North American OTC segment generates the vast majority of revenue. The largest product groups in the OTC healthcare segments include analgesics, cough and cold, gastrointestinal, and women’s health. It has customers in the United States, Canada, and Australia. Sales within the United States contribute the majority of revenue.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for PBH:NYS

Using a discounted cash flow model we generated an intrinsic value of $235.96 (USD) for PBH:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

PBH:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $235.96 1% 5% 1% 5%
WACC (or Ke) 10.84 $274.50 $206.13
Terminal Growth Rate 3.00 $210.15 $269.31
Tax Rate -2.17 $240.18 $231.74
Cash Flow 376,571,772 $222.50 $249.41
Capital Expenditures -5,502,000 $235.84 $236.08
Long Term Debt 1,479,663,000 $237.39 $234.53

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $27.79 (USD) for PBH:NYS. We also generated a valuation of $22.86 (USD) using other metrics and comparables.
The comparable companies were and Patterson Companies (PDCO:NAS).

Company PBH:NYS End Date Value
Earnings/Share $6.38 (USD)
Book Value/Share $23.06 (USD)
Sales/Share $19.23 (USD)
Cash Flow/Share $3.71 (USD)
EBITDA/Share $4.65 (USD)
Price Based on Comps Adjustment Factor (%)
$75.56 (USD) 7.4
$29.65 (USD) -18.6
$6.36 (USD) 0.0
($15.17) (USD) -44.8
$50.63 (USD) 14.4
PBH:NYS Ratios Used Average Values PDCO:NAS
4.84 PE Ratio 11.84 11.84
1.34 PB Ratio 1.29 1.29
1.61 PS Ratio 0.33 0.33
8.33 PCF Ratio 6.04 6.04
14.78 EV to EBITDA 10.88 10.88

Multiples

Using a multiples approach we generated a valuation of  $90.79 (USD) for PBH:NYS

Company PBH:NYS End Date Value
Earnings/Share $6.38 (USD)
Book Value/Share $23.06 (USD)
Sales/Share $19.23 (USD)
Cash Flow/Share $3.71 (USD)
EBITDA/Share $4.65 (USD)
Price Based on Comps Adjustment Factor
$182.43 (USD) 0
$78.42 (USD) 0
$59.79 (USD) 0
$56.17 (USD) 0
$77.15 (USD) 0
Ratios Ratio Average
PE Ratio 28.59
PB Ratio 3.40
PS Ratio 3.11
PCF Ratio 15.15
EV to EBITDA 16.58

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  PBH:NYS for the last 10 years was  3.37

We ran the Adjusted Book Value for  PBH:NYS and generated a book value of  $22.50 (USD)
By multiplying these we get an adjusted valuation of  $75.89 (USD)

Analyst Data

In the Stockcalc database there are 1 analysts that provide a valuation for PBH:NYS. The 1 analysts have a concensus valuation for PBH:NYS for 2020 of $38.00 (USD).

PBH:NYS Prestige Consumer

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
0 1 0 3.0000 Hold 2019-1-14

Current Price: 28.1 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 2.88 3.04 3.23
# EPS Analysts 1 1 1
Mean Revenue 989.40 983.80
# Revenue Analysts 1 1
Mean Target Price 38.00
Mean Cash Flow 4.02 4.12 4.30
Mean EBITDA 348.00 348.60
Mean Net Income 151.60 158.60 168.40
Mean Debt Outstanding
Mean Tax Rate 25.70 26.00 26.00
Mean Growth Rate 6.00
Mean Capital Expenditure 13.10 14.80 15.00

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Xilinx (XLNX:NAS) Fundamental Valuation Report

Fundamental Valuation Report

Xilinx(XLNX:NAS)

Technology:Semiconductors

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$91.21 (USD) 15/01/2019

Weighted Valuation
$93.48 (USD)

Overall Rating
Fairly valued to slightly Undervalued by 2.5%

Valuation Models Analyst Consensus: $95.00 (USD)
(in order of importance) Comparables: $91.21 (USD)
Valuation Methods This company is:
Cash Flow: Overvalued on a Cash Flow Valuation
Comparable Company: Fairly valued on a Comparable Valuation
Asset: Overvalued on an Asset Valuation

Company Overview (XLNX:NAS USD)

Price 91.21
Range 90.86 – 92.51
52 week 62.82 – 94.63
Open 91.18
Vol / Avg. 1.96M/2.68M
Mkt cap 23.08B
P/E 36.32
Div/yield 1.40/0.02
EPS 1.99
Shares 253.04M
Beta 0.90

Company Description

Founded in 1984, Xilinx is the top designer of programmable logic devices by market share. Its chips are critical in the performance of various devices in the communications, data processing, industrial, consumer, and automotive markets. Xilinx designs and sells chips, but it outsources manufacturing to third-party chip foundries such as United Microelectronics.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for XLNX:NAS

Using a discounted cash flow model we generated an intrinsic value of $56.93 (USD) for XLNX:NAS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

XLNX:NAS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $56.93 1% 5% 1% 5%
WACC (or Ke) 7.37 $73.01 $46.24
Terminal Growth Rate 2.40 $47.24 $71.51
Tax Rate 0.32 $61.27 $52.60
Cash Flow 1,210,060,800 $53.92 $59.95
Capital Expenditures -36,107,800 $56.84 $57.02
Long Term Debt 1,586,106,000 $57.25 $56.62

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $91.21 (USD) for XLNX:NAS. We also generated a valuation of $83.22 (USD) using other metrics and comparables.
The comparable companies were Analog Devices (ADI:NAS), Maxim Integrated Products (MXIM:NAS), NVIDIA (NVDA:NAS), Qualcomm (QCOM:NAS) and Skyworks Solutions (SWKS:NAS).

Company XLNX:NAS End Date Value
Earnings/Share $2.32 (USD)
Book Value/Share $9.66 (USD)
Sales/Share $10.76 (USD)
Cash Flow/Share $3.60 (USD)
EBITDA/Share $3.51 (USD)
Price Based on Comps Adjustment Factor (%)
$47.03 (USD) -54.6
$185.69 (USD) 40.4
$52.62 (USD) 44.7
$52.39 (USD) -5.6
$51.88 (USD) -6.7
XLNX:NAS Ratios Used Average Values ADI:NAS MXIM:NAS NVDA:NAS QCOM:NAS SWKS:NAS
36.71 PE Ratio 20.27 21.62 28.25 17.85 0.00 13.38
8.82 PB Ratio 19.22 2.89 7.37 8.59 74.34 2.90
7.92 PS Ratio 4.89 5.19 5.69 6.74 3.66 3.17
23.67 PCF Ratio 16.43 13.18 17.94 19.91 21.38 9.74
19.97 EV to EBITDA 14.79 13.86 12.29 15.33 25.78 6.71

Multiples

Using a multiples approach we generated a valuation of  $59.56 (USD) for XLNX:NAS

Company XLNX:NAS End Date Value
Earnings/Share $2.32 (USD)
Book Value/Share $9.66 (USD)
Sales/Share $10.76 (USD)
Cash Flow/Share $3.60 (USD)
EBITDA/Share $3.51 (USD)
Price Based on Comps Adjustment Factor
$58.43 (USD) 0
$52.17 (USD) 0
$68.89 (USD) 0
$64.87 (USD) 0
$53.45 (USD) 0
Ratios Ratio Average
PE Ratio 25.18
PB Ratio 5.40
PS Ratio 6.40
PCF Ratio 18.03
EV to EBITDA 15.24

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  XLNX:NAS for the last 10 years was  5.24

We ran the Adjusted Book Value for  XLNX:NAS and generated a book value of  $9.65 (USD)
By multiplying these we get an adjusted valuation of  $50.60 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for XLNX:NAS. The 3 analysts have a concensus valuation for XLNX:NAS for 2020 of $95.00 (USD).

XLNX:NAS Xilinx

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 1 0 4.0000 Outperform 2019-1-14

Current Price: 91.21 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 3.27 3.66 4.12
# EPS Analysts 5 5 2
Mean Revenue 2,979.30 3,236.60 3,568.60
# Revenue Analysts 4 4 2
Mean Target Price 95.00
Mean Cash Flow 3.77 4.31
Mean EBITDA 977.90 1,059.70 1,181.70
Mean Net Income 833.00 923.70 700.60
Mean Debt Outstanding 908.90 240.30
Mean Tax Rate 10.50 11.50 11.50
Mean Growth Rate 15.85
Mean Capital Expenditure 64.70 67.50

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


CA (CA.DL:NAS) Fundamental Valuation Report

Fundamental Valuation Report

CA(CA.DL:NAS)

Technology:Software-Infrastructure

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$44.44 (USD) 14/11/2018

Weighted Valuation
$41.84 (USD)

Overall Rating
Overvalued by 5.9%

Valuation Models Analyst Consensus: $40.75 (USD)
(in order of importance) Comparables: $41.39 (USD)
Adjusted Book Value: $45.99 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Overvalued on a Comparable Valuation
Asset: Fairly valued on an Asset Valuation

Company Overview (CA.DL:NAS USD)

Price 0.00
Range 0.00 – 0.00
52 week 0.00 – 0.00
Open 0.00
Vol / Avg. 0/0
Mkt cap 0
P/E 0.00
Div/yield 0.00/0.00
EPS 0.00
Shares 0
Beta 0.00

Company Description

CA Technologies develops and sells software and services through three business segments: mainframe solutions, enterprise solutions, and services. Mainframe solutions helps customers lower the cost of mainframe management and maintenance; enterprise solutions helps customers manage and service nonmainframe IT platforms; and the services business helps customers with implementation, training, and deployment. The mainframe solutions segment contributes over 50% of the firm’s revenue and the majority of its profits.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for CA.DL:NAS

Using a discounted cash flow model we generated an intrinsic value of $53.85 (USD) for CA.DL:NAS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

CA.DL:NAS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $53.85 1% 5% 1% 5%
WACC (or Ke) 5.88 $68.72 $43.96
Terminal Growth Rate 0.90 $44.82 $67.44
Tax Rate 0.19 $57.86 $49.85
Cash Flow 1,767,697,846 $50.53 $57.18
Capital Expenditures -52,200,000 $53.76 $53.94
Long Term Debt 1,950,000,000 $54.09 $53.62

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $41.39 (USD) for CA.DL:NAS. We also generated a valuation of $116.24 (USD) using other metrics and comparables.
The comparable companies were Citrix Systems (CTXS:NAS), F5 Networks (FFIV:NAS), Fair Isaac (FICO:NYS), Ultimate Software Group (ULTI:NAS) and VMware (VMW:NYS).

Company CA.DL:NAS End Date Value
Earnings/Share $0.97 (USD)
Book Value/Share $18.89 (USD)
Sales/Share $9.66 (USD)
Cash Flow/Share $2.68 (USD)
EBITDA/Share $3.61 (USD)
Price Based on Comps Adjustment Factor (%)
$69.82 (USD) -72.7
$0.00 (USD) -59.9
$56.04 (USD) -28.8
$47.31 (USD) -48.9
$92.67 (USD) -66.9
CA.DL:NAS Ratios Used Average Values CTXS:NAS FFIV:NAS FICO:NYS ULTI:NAS VMW:NYS
45.81 PE Ratio 71.98 104.55 22.14 40.92 154.01 38.30
2.35 PB Ratio 12.13 17.87 7.64 20.53 9.47 5.15
4.60 PS Ratio 5.80 5.15 4.65 5.65 7.05 6.51
16.56 PCF Ratio 20.12 14.02 13.20 26.14 31.06 16.19
15.23 EV to EBITDA 25.69 16.01 13.13 24.40 62.06 12.86

Multiples

Using a multiples approach we generated a valuation of  $32.02 (USD) for CA.DL:NAS

Company CA.DL:NAS End Date Value
Earnings/Share $0.97 (USD)
Book Value/Share $18.89 (USD)
Sales/Share $9.66 (USD)
Cash Flow/Share $2.68 (USD)
EBITDA/Share $3.61 (USD)
Price Based on Comps Adjustment Factor
$16.90 (USD) 0
$45.46 (USD) 0
$31.94 (USD) 0
$34.72 (USD) 0
$31.08 (USD) 0
Ratios Ratio Average
PE Ratio 17.43
PB Ratio 2.41
PS Ratio 3.31
PCF Ratio 12.94
EV to EBITDA 8.62

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  CA.DL:NAS for the last 10 years was  2.40

We ran the Adjusted Book Value for  CA.DL:NAS and generated a book value of  $19.18 (USD)
By multiplying these we get an adjusted valuation of  $45.99 (USD)

Analyst Data

In the Stockcalc database there are 2 analysts that provide a valuation for CA.DL:NAS. The 2 analysts have a concensus valuation for CA.DL:NAS for 2019 of $40.75 (USD).

CA.DL:NAS CA

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
0 3 0 3.0000 Hold 2018-11-13

Current Price: 44.44 USD

Analyst Consensus
USD Millions 2019 2020
Mean EPS 2.79 2.85
# EPS Analysts 4 4
Mean Revenue 4,271.20 4,309.80
# Revenue Analysts 2 2
Mean Target Price 40.75
Mean Cash Flow 2.80 3.11
Mean EBITDA 1,537.70 1,608.00
Mean Net Income 1,151.60 1,169.40
Mean Debt Outstanding -990.30 -1,474.70
Mean Tax Rate
Mean Growth Rate 3.23
Mean Capital Expenditure 51.30 50.70

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Plantronics (PLT:NYS) Fundamental Valuation Report

Fundamental Valuation Report

Plantronics(PLT:NYS)

Technology:Communication Equipment

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$35.48 (USD) 15/01/2019

Weighted Valuation
$66.61 (USD)

Overall Rating
Undervalued by 87.7%

Valuation Models Comparables: $67.58 (USD)
(in order of importance) Discounted Cash Flow: $65.16 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Undervalued on a Comparable Valuation
Asset: Undervalued on an Asset Valuation

Company Overview (PLT:NYS USD)

Price 35.48
Range 35.07 – 35.73
52 week 31.24 – 82.21
Open 35.10
Vol / Avg. 411149/551817
Mkt cap 1.41B
P/E 0.00
Div/yield 0.60/0.01
EPS -0.03
Shares 39.8M
Beta 1.33

Company Description

Plantronics Inc designs and manufactures lightweight communications headsets, telephone headset systems, and other communications endpoints. The firm’s headsets are used for unified communications applications in contact centers, with mobile devices and Internet telephony, for gaming, and for other applications. Its products are shipped through a network of distributors, retailers, wireless carriers, original equipment manufacturers, and other service providers. More than half of the firm’s revenue is generated in the United States, with the rest coming from Europe, Africa, Asia Pacific, and other regions.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for PLT:NYS

Using a discounted cash flow model we generated an intrinsic value of $65.16 (USD) for PLT:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

PLT:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $65.16 1% 5% 1% 5%
WACC (or Ke) 8.39 $82.84 $53.02
Terminal Growth Rate 3.00 $54.23 $81.06
Tax Rate 0.01 $68.77 $61.55
Cash Flow 169,506,464 $61.59 $68.73
Capital Expenditures 0 $65.16 $65.16
Long Term Debt 490,334,000 $65.78 $64.54

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $57.32 (USD) for PLT:NYS. We also generated a valuation of $67.58 (USD) using other metrics and comparables.
The comparable companies were Acacia Communications (ACIA:NAS), CommScope Holding Co (COMM:NAS), Finisar (FNSR:NAS), Lumentum Holdings (LITE:NAS) and Viasat (VSAT:NAS).

Company PLT:NYS End Date Value
Earnings/Share ($3.20) (USD)
Book Value/Share $19.85 (USD)
Sales/Share $33.69 (USD)
Cash Flow/Share $4.24 (USD)
EBITDA/Share $4.31 (USD)
Price Based on Comps Adjustment Factor (%)
$0.00 (USD) -53.0
$45.86 (USD) 40.7
$76.67 (USD) 17.5
$39.00 (USD) -42.3
$83.72 (USD) -36.7
PLT:NYS Ratios Used Average Values ACIA:NAS COMM:NAS FNSR:NAS LITE:NAS VSAT:NAS
0.00 PE Ratio 12.05 0.00 14.77 0.00 9.34 0.00
1.67 PB Ratio 2.31 3.01 1.80 1.58 3.29 1.88
0.98 PS Ratio 2.28 4.83 0.69 1.94 1.95 1.96
7.80 PCF Ratio 12.61 22.78 5.22 13.76 8.99 12.27
24.78 EV to EBITDA 19.43 0.00 7.89 29.34 10.24 30.25

Multiples

Using a multiples approach we generated a valuation of  $69.20 (USD) for PLT:NYS

Company PLT:NYS End Date Value
Earnings/Share ($3.20) (USD)
Book Value/Share $19.85 (USD)
Sales/Share $33.69 (USD)
Cash Flow/Share $4.24 (USD)
EBITDA/Share $4.31 (USD)
Price Based on Comps Adjustment Factor
$0.00 (USD) 0
$94.96 (USD) 0
$72.12 (USD) 0
$57.53 (USD) 0
$52.21 (USD) 0
Ratios Ratio Average
PE Ratio 21.03
PB Ratio 4.78
PS Ratio 2.14
PCF Ratio 13.56
EV to EBITDA 12.12

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  PLT:NYS for the last 10 years was  4.67

We ran the Adjusted Book Value for  PLT:NYS and generated a book value of  $23.76 (USD)
By multiplying these we get an adjusted valuation of  $110.87 (USD)

Analyst Data

In the Stockcalc database there are 0 analysts that provide a valuation for PLT:NYS.

PLT:NYS Plantronics

No analyst recommendation
Current Price: not available

No analyst consensus

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


CommVault Systems (CVLT:NAS) Fundamental Valuation Report

Fundamental Valuation Report

CommVault Systems(CVLT:NAS)

Technology:Software-Application

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$61.08 (USD) 15/01/2019

Weighted Valuation
$62.04 (USD)

Overall Rating
Fairly valued to slightly Undervalued by 1.6%

Valuation Models Analyst Consensus: $65.00 (USD)
(in order of importance) Comparables: $63.67 (USD)
Adjusted Book Value: $49.90 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Fairly valued on a Comparable Valuation
Asset: Overvalued on an Asset Valuation

Company Overview (CVLT:NAS USD)

Price 61.08
Range 59.92 – 61.25
52 week 49.75 – 71.80
Open 60.11
Vol / Avg. 234357/473883
Mkt cap 2.83B
P/E 0.00
Div/yield 0.00/0.00
EPS -1.37
Shares 46.29M
Beta 1.19

Company Description

CommVault Systems Inc provides data and information management software applications and services. Its flagship Simpana Software is delivered on a unified platform with customizable licensed modules that provide backup and recovery, archive, replication, and analytic capabilities across physical, virtual, and cloud environments. The firm sells software licenses and services to large global enterprises, small and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Most of the firm’s revenue is generated in the United States, but the firm has a presence in many other countries.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for CVLT:NAS

Using a discounted cash flow model we generated an intrinsic value of $644.25 (USD) for CVLT:NAS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

CVLT:NAS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $644.25 1% 5% 1% 5%
WACC (or Ke) 11.74 $726.73 $578.45
Terminal Growth Rate 3.00 $587.01 $716.29
Tax Rate -16.69 $646.07 $642.43
Cash Flow 181,334,545 $609.91 $678.60
Capital Expenditures -30,814,600 $641.11 $647.40
Long Term Debt 0 $644.25 $644.25

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $28.17 (USD) for CVLT:NAS. We also generated a valuation of $63.67 (USD) using other metrics and comparables.
The comparable companies were ACI Worldwide (ACIW:NAS), Blackbaud (BLKB:NAS), Ellie Mae (ELLI:NYS), Allscripts Healthcare (MDRX:NAS) and Verint Systems (VRNT:NAS).

Company CVLT:NAS End Date Value
Earnings/Share ($1.51) (USD)
Book Value/Share $9.01 (USD)
Sales/Share $15.65 (USD)
Cash Flow/Share $2.14 (USD)
EBITDA/Share $0.21 (USD)
Price Based on Comps Adjustment Factor (%)
$0.00 (USD) 0.0
$33.06 (USD) 13.4
$45.74 (USD) 15.0
$32.58 (USD) -42.1
$3.72 (USD) 0.0
CVLT:NAS Ratios Used Average Values ACIW:NAS BLKB:NAS ELLI:NYS MDRX:NAS VRNT:NAS
0.00 PE Ratio 98.80 230.58 46.94 69.04 0.00 48.63
6.56 PB Ratio 3.67 3.33 8.40 2.76 1.55 2.30
3.78 PS Ratio 2.92 3.22 3.58 4.71 0.82 2.27
27.63 PCF Ratio 15.24 20.26 15.85 17.87 9.13 13.06
156.83 EV to EBITDA 17.88 17.25 24.54 22.39 9.87 15.37

Multiples

Using a multiples approach we generated a valuation of  $44.80 (USD) for CVLT:NAS

Company CVLT:NAS End Date Value
Earnings/Share ($1.51) (USD)
Book Value/Share $9.01 (USD)
Sales/Share $15.65 (USD)
Cash Flow/Share $2.14 (USD)
EBITDA/Share $0.21 (USD)
Price Based on Comps Adjustment Factor
$0.00 (USD) 0
$48.22 (USD) 0
$58.82 (USD) 0
$54.77 (USD) 0
$17.42 (USD) 0
Ratios Ratio Average
PE Ratio 242.48
PB Ratio 5.35
PS Ratio 3.76
PCF Ratio 25.61
EV to EBITDA 83.70

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  CVLT:NAS for the last 10 years was  5.40

We ran the Adjusted Book Value for  CVLT:NAS and generated a book value of  $9.25 (USD)
By multiplying these we get an adjusted valuation of  $49.90 (USD)

Analyst Data

In the Stockcalc database there are 1 analysts that provide a valuation for CVLT:NAS. The 1 analysts have a concensus valuation for CVLT:NAS for 2020 of $65.00 (USD).

CVLT:NAS CommVault Systems

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
0 1 0 3.0000 Hold 2019-1-14

Current Price: 61.08 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 1.54 2.34 3.05
# EPS Analysts 1 1 1
Mean Revenue 715.00 780.00 850.00
# Revenue Analysts 1 1 1
Mean Target Price 65.00
Mean Cash Flow
Mean EBITDA
Mean Net Income
Mean Debt Outstanding
Mean Tax Rate
Mean Growth Rate
Mean Capital Expenditure

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


WNS (Holdings) (WNS:NYS) Fundamental Valuation Report

Fundamental Valuation Report

WNS (Holdings)(WNS:NYS)

Industrials:Business Services

This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here.

Close Price/Date
$45.36 (USD) 15/01/2019

Weighted Valuation
$51.68 (USD)

Overall Rating
Undervalued by 13.9%

Valuation Models Analyst Consensus: $57.67 (USD)
(in order of importance) Discounted Cash Flow: $51.06 (USD)
Adjusted Book Value: $34.95 (USD)
Valuation Methods This company is:
Cash Flow: Undervalued on a Cash Flow Valuation
Comparable Company: Overvalued on a Comparable Valuation
Asset: Overvalued on an Asset Valuation

Company Overview (WNS:NYS USD)

Price 45.36
Range 44.95 – 45.88
52 week 39.51 – 54.09
Open 45.10
Vol / Avg. 314610/192771
Mkt cap 2.27B
P/E 28.11
Div/yield 0.00/0.00
EPS 1.63
Shares 49.93M
Beta 0.87

Company Description

WNS (Holdings) Ltd is a global provider of business process management (BPM) services, offering comprehensive data, voice, analytical and business transformation services with a blended onshore, near shore and offshore delivery model. The company has several operating segments based on a mix of industry and the types of services. Most of its revenue comes from providing business process management services and on geographic terms from Jersey, Channel Islands. The company transfers the business processes of clients to delivery centers, located in China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Sri Lanka, the UK and the US, with a view to offer cost savings, operational flexibility, improved quality and actionable insights to the clients.

Valuation Details

 We have up to 6 valuation points for each company. Details are at the bottom of the report.

Discounted Cash Flow and Sensitivity Analysis for WNS:NYS

Using a discounted cash flow model we generated an intrinsic value of $51.06 (USD) for WNS:NYS

Sensitivity Analysis

(showing how changes in the input variables impact the DCF calculation)

WNS:NYS Current Values Valuation If Dropped * Valuation If Raised *
Calculated Value: $51.06 1% 5% 1% 5%
WACC (or Ke) 7.69 $64.04 $42.43
Terminal Growth Rate 2.70 $43.17 $62.91
Tax Rate 0.15 $54.26 $47.86
Cash Flow 182,772,240 $48.22 $53.91
Capital Expenditures -11,721,400 $50.90 $51.23
Long Term Debt 0 $51.06 $51.06

* Changes are absolute: ex WACC from 8% to 7%

Comparables Model

Using similar companies and price based ratios we generated a valuation of $24.59 (USD) for WNS:NYS. We also generated a valuation of $27.88 (USD) using other metrics and comparables.
The comparable companies were CoreLogic (CLGX:NYS), Conduent (CNDT:NYS), Deluxe (DLX:NYS), ExlService Holdings (EXLS:NAS) and FTI Consulting (FCN:NYS).

Company WNS:NYS End Date Value
Earnings/Share $1.85 (USD)
Book Value/Share $8.97 (USD)
Sales/Share $14.99 (USD)
Cash Flow/Share $2.34 (USD)
EBITDA/Share $2.67 (USD)
Price Based on Comps Adjustment Factor (%)
$38.14 (USD) 34.4
$18.26 (USD) -45.5
$18.94 (USD) -19.1
$23.89 (USD) -26.4
$26.59 (USD) 10.8
WNS:NYS Ratios Used Average Values CLGX:NYS CNDT:NYS DLX:NYS EXLS:NAS FCN:NYS
22.30 PE Ratio 20.62 15.99 0.00 10.47 42.78 13.22
4.60 PB Ratio 2.04 2.61 0.67 1.86 3.14 1.89
2.75 PS Ratio 1.26 1.50 0.42 0.93 2.19 1.27
17.62 PCF Ratio 10.93 7.61 8.71 5.53 20.70 12.09
14.92 EV to EBITDA 9.97 9.64 9.47 6.75 14.40 9.59

Multiples

Using a multiples approach we generated a valuation of  $40.90 (USD) for WNS:NYS

Company WNS:NYS End Date Value
Earnings/Share $1.85 (USD)
Book Value/Share $8.97 (USD)
Sales/Share $14.99 (USD)
Cash Flow/Share $2.34 (USD)
EBITDA/Share $2.67 (USD)
Price Based on Comps Adjustment Factor
$49.56 (USD) 0
$35.91 (USD) 0
$43.12 (USD) 0
$38.85 (USD) 0
$37.06 (USD) 0
Ratios Ratio Average
PE Ratio 26.79
PB Ratio 4.00
PS Ratio 2.88
PCF Ratio 16.59
EV to EBITDA 13.90

Adjusted Book Value versus Historical Price to Book

The average the Price to Book ratio for  WNS:NYS for the last 10 years was  3.93

We ran the Adjusted Book Value for  WNS:NYS and generated a book value of  $8.88 (USD)
By multiplying these we get an adjusted valuation of  $34.95 (USD)

Analyst Data

In the Stockcalc database there are 3 analysts that provide a valuation for WNS:NYS. The 3 analysts have a concensus valuation for WNS:NYS for 2020 of $57.67 (USD).

WNS:NYS WNS (Holdings)

Analyst Recommendation
Buy Hold Sell Rating
(of 5)
Guidance As Of
3 0 0 5.0000 Buy 2019-1-14

Current Price: 45.36 USD

Analyst Consensus
USD Millions 2019 2020 2021
Mean EPS 2.55 2.68 3.00
# EPS Analysts 3 2 1
Mean Revenue 792.10 863.50 959.80
# Revenue Analysts 2 2 1
Mean Target Price 57.67
Mean Cash Flow
Mean EBITDA
Mean Net Income 131.10 138.90 152.40
Mean Debt Outstanding
Mean Tax Rate 21.40 24.00
Mean Growth Rate 12.60
Mean Capital Expenditure

Explanation of Valuation Models

We have up to 6 valuation points for each company in the database.

The Discounted Cash Flow (DCF) valuation is a cash flow model where cash flow projections are discounted back to the present to calculate value per share. DCF is a common valuation technique especially for companies undergoing irregular cash flows such as resource companies (mining, forestry, oil and gas) going though price cycles or smaller companies about to generate cash flow (junior exploration companies, junior pharma, technology firms…).

The Price Comparables valuation is the result of valuing the company we are looking at on the basis of ratios from selected comparable companies: Price to Earnings, Price to Book, Price to Sales, Price to Cash Flow, Enterprise Value (EV) to EBITDA. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

We have included the Other Comparables as a way to value companies that cannot be valued using Earnings based ratios. This technique is very useful for companies still experiencing negative cash flows such as mining exploration firms. We use Cash/Share, Book Value/Share, MarketCap, 1 Year Return, NetPPE as the ratios here. Each of these ratios for the selected comparable companies are averaged and multiplied by the values for the company we are interested in to calculate a value per share for our selected company.

Multiples are similar to Price comparables where we look at current or historic ratios for the company in question to assess what it should be worth today based on those historic ratios. We use the same 5 ratios as in the price comparables and value the company with its historic averages.

With Adjusted Book Value (ABV) we calculate the book value per share for the company based on its balance sheet and multiply that book value per share by its historical price to book ratio to calculate a value per share.

If we have Analyst coverage for the company we use the consensus target price here.

Notice to User


The contents of this report and the Stockcalc website are provided on an ‘‘as is’’ or ‘‘as available’’ basis with all faults and may not be current in all cases. The information in this report or on the website is subject to continuous change and Patchell Brook Equity Analytics Inc. assumes no responsibility to update or amend such information or that the information will be current. Patchell Brook Equity Analytics Inc. does not claim that all information, calculations or opinions presented in this report or on its website are true, reliable, or complete. Accordingly, you should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment or other decision. Any information, data, opinions, calculations or recommendations provided by third parties through links to other websites or otherwise made available through this report or website are solely those of the third party and not of Patchell Brook Equity Analytics Inc. Please refer to the Terms of Use on stockcalc.com for further information.
To access all of the tools on Stockcalc, including more detailed valuation reports and the models used to generate these valuations, please subscribe for a free 30 day trial of Stockcalc here.


Intel (INTC:NAS) and Baidu (BIDU:NAS) Downgraded

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/toppicks.aspx.

Downgraded Stocks on NYSE, NASDAQ, AMEX, TSE, and TSX

Today we are looking at companies whose share price has been downgraded by at least one analyst in the last few days.

Why Do Companies Get Downgraded?

Companies can get downgraded for a number of reasons but primarily due to reduced future earnings potential due to loss of contracts, faultering product lines, increasing costs relative to revenue or financial risk.

In the list below you can see the number of analysts we have in the StockCalc database along with the number of buy-hold-sell on the company.

Today’s Data on NYSE, NASDAQ, AMEX, TSE, and TSX

Below we have today’s data for companies listed on all of the New York Stock Exchange, NASDAQ Stock Exchange, American Stock Exchange, Toronto Stock Exchange, and TSX Venture Exchange.

New York Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CP Canadian Pacific Railway Ltd 13 6 0 0 0 0 4.6842 4.7222 Buy
RSG Republic Services Inc 1 0 3 1 0 0 3.2000 3.6000 Hold
MT ArcelorMittal SA 3 0 0 1 0 0 4.2500 4.4000 Outperform
TAL TAL Education Group 2 0 1 0 0 0 4.3333 4.5000 Outperform
PBA Pembina Pipeline Corp 8 7 1 0 0 0 4.4375 4.5000 Outperform
ENIA Enel Americas SA 0 1 0 0 0 0 4.0000 4.5000 Outperform
WRK WRKCo Inc 3 1 1 0 0 0 4.4000 4.8000 Outperform
CF CF Industries Holdings Inc 2 0 4 0 0 0 3.6667 4.0000 Outperform
MHK Mohawk Industries Inc 3 1 2 0 1 0 3.7143 4.0000 Outperform
GG Goldcorp Inc 7 4 4 0 1 0 4.0000 4.1875 Outperform
PHM PulteGroup Inc 1 1 1 0 1 0 3.2500 3.7500 Hold
RH RH 0 0 3 1 0 0 2.7500 3.2000 Hold
OSB Norbord Inc 4 1 2 0 1 0 3.8750 4.1250 Outperform
JELD JELD-WEN Holding Inc 2 0 3 0 0 0 3.8000 4.2000 Outperform
IBP Installed Building Products Inc 0 0 3 0 0 0 3.0000 3.6667 Hold
EGO Eldorado Gold Corp 1 2 8 0 3 0 2.8571 3.0000 Hold
FBM Foundation Building Materials Inc 2 0 2 0 0 0 4.0000 4.3333 Outperform
Toronto Stock Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
CP Canadian Pacific Railway Ltd 13 6 0 0 0 0 4.6842 4.7222 Buy
H Hydro One Ltd 0 1 9 0 2 0 2.7500 2.8333 Hold
G Goldcorp Inc 7 4 4 0 1 0 4.0000 4.1875 Outperform
OSB Norbord Inc 4 1 2 0 1 0 3.8750 4.1250 Outperform
LIF Labrador Iron Ore Royalty Corp 0 0 1 0 0 0 3.0000 3.5000 Hold
GUD Knight Therapeutics Inc 2 5 2 0 0 0 4.0000 4.1250 Outperform
ELD Eldorado Gold Corp 1 2 8 0 3 0 2.8571 3.0000 Hold
LMC Leagold Mining Corp 4 3 1 0 0 0 4.3750 4.6250 Outperform
TV Trevali Mining Corp 6 5 1 0 0 0 4.4167 4.5000 Outperform
S Sherritt International Corp 0 2 2 0 0 0 3.5000 4.2500 Hold
TSX Venture Exchange
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
GRA NanoXplore Inc 1 3 0 0 0 0 4.2500 4.3333 Outperform
NASDAQ
Symbol Name Buy Out Perform Hold Under Perform Sell No Opinion Mean Rating Prev Mean Rating Mean Label
INTC Intel Corp 5 1 3 0 2 0 3.6364 3.7273 Outperform
BIDU Baidu Inc 5 0 1 0 0 0 4.6667 5.0000 Buy
NTES NetEase Inc 3 1 1 0 0 0 4.4000 4.7500 Outperform
JD JD.com Inc 3 0 1 0 0 0 4.5000 5.0000 Outperform
INCY Incyte Corp 2 1 2 0 0 0 4.0000 4.1667 Outperform
CTRP Ctrip.com International Ltd 4 0 2 0 0 0 4.3333 4.6000 Outperform
IQ iQIYI Inc 1 0 0 0 1 0 3.0000 5.0000 Hold
CASY Casey’s General Stores Inc 2 0 1 0 0 0 4.3333 4.5000 Outperform
WIX Wix.com Ltd 2 0 1 0 0 0 4.3333 4.5000 Outperform
PTEN Patterson-UTI Energy Inc 6 0 1 1 0 0 4.3750 4.4444 Outperform
BLDR Builders FirstSource Inc 2 0 2 0 0 0 4.0000 4.5000 Outperform
PSDO Presidio Inc 0 0 1 0 0 0 3.0000 4.0000 Hold
BMCH BMC Stock Holdings Inc 3 0 2 0 0 0 4.2000 4.5000 Outperform
SOHU Sohu.com Ltd 0 0 1 0 0 0 3.0000 4.0000 Hold
FTSV Forty Seven Inc 3 0 1 0 0 0 4.5000 5.0000 Outperform

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

INTC:NAS Intel

http://www.intel.com
Intel has 102700 employees and is headquartered in United States.
Intel Corp is the world’s largest chipmaker. It engaged in making a semiconductor chip. It designs and manufactures integrated digital technology products like integrated circuits, for industries such as computing and communications.

BIDU:NAS Baidu

http://www.ir.baidu.com
Baidu has 39343 employees and is headquartered in China.
Baidu Inc is one of the world’s leading Chinese-language Internet search engine. The company through its website primarily serves over 0.8 million advertisers which include small and medium-size businesses.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.

MAG Silver (MAG:ASE) and Goodrich Petroleum (GDP:ASE) Are Undervalued

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Undervalued Stocks on AMEX

Today we are looking at companies that are considered undervalued based on the Analyst data in the StockCalc database.

In the table below we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.

There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.

Today’s Data on AMEX

Today’s data is for companies listed on the American Stock Exchange.

Symbol Name Target Year Close Price Target Price Mean Currency Target Price # of Estimates
LNG Cheniere Energy Inc 2019 64.500000 77.0000 USD 3
MAG MAG Silver Corp 2019 8.280000 19.8789 CAD 8
REI Ring Energy Inc 2019 6.110000 12.5000 USD 2
GSS Golden Star Resources Ltd 2019 3.300000 7.3356 CAD 7
UUUU Energy Fuels Inc 2019 2.910000 6.4083 CAD 1
RLGT Radiant Logistics Inc 2019 4.760000 8.2500 USD 2
BGSF BG Staffing Inc 2019 22.010000 30.2500 USD 2
GDP Goodrich Petroleum Corp 2019 14.500000 21.5000 USD 2
PTN Palatin Technologies Inc 2019 0.720000 5.5000 USD 2
DLA Delta Apparel Inc 2019 18.790000 24.0000 USD 1
LLEX Lilis Energy Inc 2019 1.790000 6.0000 USD 1
MTNB Matinas BioPharma Holdings Inc 2019 1.000000 5.0000 USD 1
CVU CPI Aerostructures Inc 2019 6.930000 12.0000 USD 1
USAS Americas Silver Corp 2019 1.620000 5.7000 CAD 3
PLYM Plymouth Industrial REIT Inc 2019 14.290000 20.0000 USD 1
OCX OncoCyte Corp 2019 1.530000 7.0000 USD 1
PLX Protalix BioTherapeutics Inc 2019 0.397900 4.0000 USD 1
ATNM Actinium Pharmaceuticals Inc 2019 0.430000 4.5000 USD 4
ACU Acme United Corp 2019 15.230000 23.2500 USD 2
RNN Rexahn Pharmaceuticals Inc 2019 1.250000 17.0000 USD 1
FTNW FTE Networks Inc 2019 2.290000 20.5000 USD 2
AST Asterias Biotherapeutics Inc 2019 0.740100 11.0000 USD 1
CANF Can Fite Biofarma Ltd 2019 1.170000 8.0000 USD 1
SYN Synthetic Biologics Inc 2019 0.652600 6.0000 USD 1
APHB Ampliphi Biosciences Corp 2019 0.265100 3.5000 USD 1

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

MAG:ASE MAG Silver

http://www.magsilver.com
MAG Silver has 8 employees and is headquartered in Canada.
MAG Silver Corp is a mineral exploration and development company based in Canada. The group focuses on district-scale projects in the Mexican Silver Belt, and its main source of revenue is interest income from high interest savings accounts.

GDP:ASE Goodrich Petroleum

http://www.goodrichpetroleum.com
Goodrich Petroleum has 48 employees and is headquartered in United States.
Goodrich Petroleum Corp is an independent oil and natural gas company. It is engaged in the exploration, development and production of oil and natural gas in the Tuscaloosa Marine Shale region.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.